PDS Biotechnology (PDSB) Tops Q1 EPS by 2c

PDS Biotechnology (NASDAQ: PDSB) reported Q1 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Google execs convened 'all-hands' meeting last week to address AI unit reorganizations amid staff concerns - Reuters
• Cencora says Walgreens volumes shift, reaffirms guidance, shares sink
• The Honest Co. (HNST) PT Raised to $5.70 at Morgan Stanley, 'Diaper Pressure Continues'